+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

SR 27417, a novel, highly potent and long-acting PAF receptor antagonist



SR 27417, a novel, highly potent and long-acting PAF receptor antagonist



Journal of Lipid Mediators & Cell Signalling 10(1-2): 149-150




Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 033286517

Download citation: RISBibTeXText


Related references

SR 27417, a highly potent, selective and long-acting antagonist of the PAF receptor. Drugs of the Future 17(11): 1011-1018, 1992

Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist. Journal of Pharmacology and Experimental Therapeutics 259(1): 44-51, 1991

BRL 46470A: A highly potent, selective and long acting 5-HT-3 receptor antagonist with anxiolytic-like properties. Psychopharmacology 110(3): 257-264, 1993

Pharmacological Profiles of a Highly Potent and Long-Acting Angiotensin II Receptor Antagonist, Fimasartan, in Rats and Dogs after Oral Administration. Biological and Pharmaceutical Bulletin 40(7): 992-1001, 2018

Pharmacological profile of a highly potent and long-acting angiotensin II receptor antagonist, 2-ethoxy-1 biphenyl-4-yl-1H-benzimidazole-7-carboyxlic acid. Journal of Pharmacology & Experimental Therapeutics 266(1): 114-120, 1993

Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, -1- ethyl 2-ethoxy-1- bipenyl-4-yl-methyl-1H-benzimidazole-7-carboxylate. Journal of Pharmacology & Experimental Therapeutics 268(3): 1540-1547, 1994

Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H- benzimidazole-7-carboxylate (TCV-116), in various hypertensive rats. Journal of Pharmacology and Experimental Therapeutics 268(3): 1540-1547, 1994

HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats. European Journal of Pharmacology 200(1): 179-182, 1991

Lerisetron A new potent, selective and long acting 5-HT3 receptor antagonist. Methods & Findings in Experimental & Clinical Pharmacology 19(SUPPL A): 103, 1997

Skf 93574 a potent and long acting histamine h 2 receptor antagonist for intravenous administration. British Journal of Pharmacology 86(SUPPL): 570P, 1985

A potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist. Bioorganic & Medicinal Chemistry Letters. 4(1): 23-28, 1994

Skf 93574 preliminary evaluation of a potent and long acting parenteral h 2 receptor antagonist in man. Gut 26(10): A1107, 1985

Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin II AT-1 receptor antagonist. FASEB Journal 8(4-5): A832, 1994

Pharmacology of a potent long-acting imidazole-5-acrylic acid angiotensin AT1 receptor antagonist. European Journal Of Pharmacology. 283(1-3): 63-72, 1995

In vitro inhibitory effect of SR 27417, a potent platelet-activating factor (PAF) receptor antagonist, on the PAF-induced bovine platelet aggregation. Veterinary Research 31(2): 267-272, 2000